Medpace Holdings (MEDP) Enterprise Value (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Enterprise Value data on file, last reported at -$502.7 million in Q2 2026.

• Quarterly Enterprise Value fell 985.02% year-over-year to -$502.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$502.7 million (down 985.02% YoY) and the FY2025 annual result came in at -$497.0 million, up 25.75% from the prior year.
• Enterprise Value advanced to -$502.7 million in Q2 2026, from -$652.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$28.3 million in Q4 2022 to a low of -$669.4 million in Q4 2024.
• A 5-year average of -$293.4 million and a median of -$265.4 million in 2023 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 93.87% — and 2024, when it sank 1205.37%.
• Tracing MEDP's Enterprise Value over 5 years: stood at -$28.3 million in 2022, then plunged by 768.38% to -$245.4 million in 2023, then sank by 172.74% to -$669.4 million in 2024, then increased by 25.75% to -$497.0 million in 2025, then retreated by 1.13% to -$502.7 million in 2026.
• The last three Enterprise Value figures came in at -$502.7 million (Q2 2026), -$652.7 million (Q1 2026), and -$497.0 million (Q4 2025), per Business Quant data.